Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-15 (IL-15) is a pleiotropic cytokine belonging to the 4-alpha helix bundle family that plays a central role in both innate and adaptive immunity. It modulates the development, survival, proliferation, and activation of various immune cell types, including Natural Killer (NK) cells, CD8+ memory T cells, NKT cells, γδ T cells and ILC1 cells. Dysregulated IL-15 production has been implicated in autoimmune diseases and cancer. Recombinant forms and agonists are under development for cancer immunotherapy.
IL-15 interacts with a heterotrimeric receptor complex consisting of IL-15Rα, IL-2/IL-15Rβ, and the common γ chain (*γc*), activating downstream signaling pathways like JAK1/JAK3 → STAT3/STAT5, p38 MAPK, and NF-kB to promote lymphocyte proliferation, survival, and activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 15 (IL-15).